U.S. Insurance Stock News

S&P Global Ratings recently confirmed Freedom Holding Corp.’s long-term issuer credit rating at “B-” with a Stable outlook, while assigning Positive outlooks to key operating subsidiaries as the group expands its brokerage, banking, and broader financial ecosystem. The inclusion of newer areas such as telecommunications and artificial intelligence within Freedom Holding’s growing ecosystem highlights how the group is broadening its business mix beyond traditional financial services. We’ll...

In late February 2026, TeraWulf reported full-year 2025 revenue of US$168.46 million, a net loss of US$661.42 million, and held a lender construction update call for its WULF Compute subsidiary. Alongside these results, the company’s shift from bitcoin mining toward high-performance computing, backed by multi-billion-dollar Google support and new private capital, marked a major repositioning of its business model. Next, we’ll examine how Google’s expanded US$3.20 billion backstop and related...

Voss Capital’s public letter to Euronet Worldwide (EEFT) on March 4 has put the stock in focus, as the activist shareholder pressed the board to consider “strategic alternatives” after multi year share price underperformance. See our latest analysis for Euronet Worldwide. The activist letter appears to have sharpened attention on a stock that has struggled for some time, with a 1 year total shareholder return of 28.09% and a 5 year total shareholder return of 53.58%. At the same time, the 7...

Douglas Dynamics, Inc. has already reported fourth-quarter 2025 results, with sales rising to US$184.54 million and net income reaching US$12.84 million, alongside full-year 2025 sales of US$656.05 million and a quarterly dividend of US$0.295 per share declared for payment on March 31, 2026. Management’s 2026 net sales outlook of US$710 million to US$760 million, combined with higher quarterly earnings versus the prior year, has prompted analysts to reassess how earnings quality, demand...

Why Stepan’s latest earnings matter for shareholders Stepan (SCL) just released fourth quarter and full year 2025 results, pairing higher quarterly sales and net income with a goodwill impairment charge and a reaffirmed quarterly cash dividend of $0.395 per share. This mix of earnings, impairment and dividend news gives you a fresh look at how the chemical producer is balancing reported profitability, balance sheet adjustments and ongoing cash returns to shareholders. See our latest analysis...

Over the past week, Equity Residential has seen a flurry of analyst rating updates, an upgrade from Wall Street Zen, and increased institutional ownership by Dimensional Fund Advisors, alongside insider share sales and ongoing development of 935 new apartment units in major U.S. metros. This cluster of analyst opinions and institutional repositioning highlights how divided professional investors are on Equity Residential’s outlook, even as interest in its multifamily portfolio remains...

Canadian Solar (CSIQ) is back in focus after its Recurrent Energy unit closed the sale of the 200 MWh Fort Duncan Battery Storage facility and its e-STORAGE arm delivered a first grid-connected system in Japan. See our latest analysis for Canadian Solar. These storage milestones come at a time when momentum in Canadian Solar's shares has been weak, with a 30 day share price return of 19.56% and a year to date share price return of 37.03%, despite a 1 year total shareholder return of 56.25%...

In early March 2026, Costco Wholesale reported February net sales of US$21.69 billion, up 9.5% year on year, and first‑half net sales of US$144.85 billion, up 8.6%, alongside fiscal Q2 results that exceeded expectations on comparable sales, membership income and e‑commerce growth. Management also signaled that any refunds from recently invalidated tariffs would be returned to members through lower prices, reinforcing Costco’s member‑first pricing philosophy at a time when it is accelerating...

Okta (OKTA) just paired a strong fourth quarter with a more cautious outlook, as record contract value and AI driven identity products met softer guidance and a fresh US$763.4m shelf registration for employee stock offerings. See our latest analysis for Okta. Okta’s 11.3% 7 day share price return and 1.3% 1 day gain suggest a positive short term reaction to earnings and AI identity news. However, the 1 year total shareholder return of 28.2% and 5 year total shareholder return of 64.4%...

AutoZone, Inc. reported past second-quarter 2026 results showing sales rising to US$4,274.10 million from US$3,952.01 million a year earlier, while net income eased to US$468.86 million and diluted EPS from continuing operations slipped to US$27.63. Alongside these mixed results, AutoZone continued its long-running capital return program, repurchasing 85,000 shares for US$310.80 million and bringing total buybacks since 2008 to about US$32.36 billion. Next, we'll examine how rising sales but...

Oscar Health recently presented at the 47th Annual Raymond James Institutional Investor Conference in Orlando, where its CFO reiterated the 2026 outlook and addressed policy and capital concerns. Management also highlighted stronger-than-expected enrollment of 3.4 million members and extensive reinsurance support, underscoring how scale and risk-sharing underpin the business model. Next, we’ll explore how this reaffirmed outlook and higher enrollment may influence Oscar Health’s investment...

In February 2026, Capital Southwest Corporation’s board declared past monthly regular dividends of US$0.1934 per share for April, May, and June 2026, with corresponding ex-dividend, record, and payment dates for each month. The company also announced a supplemental dividend of US$0.06 per share for the June 2026 quarter, underscoring its emphasis on shareholder cash returns alongside regular distributions. With the newly declared regular and supplemental dividends highlighting cash returns,...

AnaptysBio (ANAB) has drawn fresh attention after reporting a fourth quarter earnings swing to net income of US$49.61 million, supported by collaboration revenues and milestone payments tied to cancer drug Jemperli. See our latest analysis for AnaptysBio. The strong earnings swing and Jemperli related revenues arrive after a sharp rerating in the shares. The current US$55.41 price follows a 24.49% 90 day share price return and a 1 year total shareholder return of 239.11%, suggesting momentum...

In February 2026, Paychex announced new AI-driven enhancements across its Paycor and Paychex Flex platforms, including automated scheduling, time and attendance, and time-off management tools designed to streamline workforce management for small and midsized businesses. These AI features, such as human-in-the-loop smart scheduling and agent-assisted time-off approvals, reflect Paychex’s push to bring enterprise-grade automation and transparency to everyday HR tasks. Next, we’ll examine how...

In early March 2026, Bank of America Corporation issued a series of new senior unsecured notes across multiple maturities while simultaneously moving to redeem existing US dollar, euro, and yen senior notes ahead of their 2027 maturities, reshaping its funding profile. This combination of fresh fixed‑income offerings and early redemptions highlights how the bank is actively managing its liability mix and interest costs against a backdrop of sector risks and geopolitical uncertainty. We’ll...

Why Quest Diagnostics Stock Is on Investors’ Radar Quest Diagnostics (DGX) is back in focus after recent trading, with the share price last closing at $199.21. Investors are weighing that level against the company’s earnings profile, cash generation, and overall business stability. See our latest analysis for Quest Diagnostics. While the 1-day share price return of 2.34% and 7-day share price return of 5.99% have cooled sentiment a bit, the 30-day and year-to-date share price returns of 4.46%...

In late February and early March 2026, analysts including Citi, Raymond James, and Barclays turned more cautious on American Homes 4 Rent, citing softer rental demand, elevated new supply, and rising concessions across single-family and multifamily markets. At Citi’s Miami Global Property CEO Conference 2026, American Homes 4 Rent outlined its response with a new US$500 million share repurchase authorization and plans to develop about 1,900 homes in 2026 while closely tracking legislative...

In early March 2026, Arcutis Biotherapeutics reported strong 2025 results with revenue of US$376.07 million, a swing to quarterly profitability, raised its 2026 net product revenue guidance to US$480 million–US$495 million, advanced its ARQ-234 atopic dermatitis program into a Phase 1a/1b trial, and elevated Mas Matsuda to executive vice president, chief legal officer, and corporate secretary. Together, these developments point to a company moving from pure development-stage biotech toward a...

Repligen (RGEN) has been under pressure after a weaker February jobs report hit healthcare stocks, even as the company recently reported quarterly and full year 2025 results that showed positive revenue and net income figures. See our latest analysis for Repligen. At a share price of US$119.99, Repligen has seen a 1 day share price return of 4.03% decline, a 30 day share price return of 15.61% decline, and a 1 year total shareholder return of 22.94% decline. This suggests momentum has been...

Graham Holdings Company recently reported its fourth-quarter and full-year 2025 results, with quarterly sales edging up to US$1,251.02 million while net income and earnings per share from continuing operations fell sharply year over year, alongside US$10.10 million of impairment charges on intangible and other long-lived assets. The company’s decision to maintain a regular quarterly dividend of US$1.88 per share, even as full-year net income dropped significantly, highlights a continued...

Lindsay (LNN) has rolled out two new road safety products, the Road Runner Truck Mounted Attenuator and the AlphaGuard channelizing device, giving investors fresh information on its infrastructure focused portfolio. See our latest analysis for Lindsay. The recent product launches come as Lindsay's 90 day share price return of 9.67% and year to date share price return of 6.97% contrast with a 1 year total shareholder return of 0.72% decline, suggesting shorter term momentum has picked up after...

CNO Financial Group recently expanded its retirement offerings through Bankers Life’s Enhanced Death Benefit Rider for its Guaranteed Lifetime Income Annuity products, while its survey of Americans aged 50 to 85 highlighted growing concerns about inflation, longevity risk, and potential Social Security changes. Together, the new rider and survey insights underline how middle-income retirees are increasingly focused on balancing guaranteed income with the ability to leave a financial legacy...

Quarterly earnings and dividend catch investors’ attention Smith & Wesson Brands (SWBI) recently reported third quarter results alongside a fresh dividend announcement. This gives investors new data on both operating performance and direct cash returns. For the quarter ended January 31, 2026, sales were US$135.71 million compared with US$115.89 million a year earlier, while net income was US$3.75 million versus US$2.10 million. See our latest analysis for Smith & Wesson Brands. The earnings...

In February 2026, RLI Corp. completed a US$299.93 million fixed-rate senior unsecured notes offering, issuing 5.375% callable notes due June 1, 2036, alongside an amended and restated credit agreement with PNC Bank that extended maturity and expanded committed capacity. This combination of long-dated debt and enhanced bank financing reshapes RLI’s capital structure, potentially giving management more room to fund growth projects and manage liquidity across insurance cycles. Next, we’ll...